FDA Finalizing Good Review Management Principles; “Heavily Revised” Guidance Coming Soon

The final guidance will emphasize “principles that underlie” review decisions, Office of New Drugs director tells DIA. FDA will also lay out “a model review process.” The final guidance should be out later this year.